Given the relationship between BMI, obesity, adiponectin, and Alzheimer's disease [54–56], we speculate that the methylation of the CpG site at − 74 nt of the ADIPOQ gene promoter in peripheral blood is associated with Alzheimer’s disease. Here, ADIPOQ is linked to early-onset autosomal dominant Alzheimer disease.